Proposes a constitutional amendment relating to products derived from cannabis plants

Legislative bill overview

HJR 106 proposes a constitutional amendment in Missouri that would modify state law regarding products derived from cannabis plants. The bill seeks to alter the constitutional framework governing how cannabis-derived products are regulated, produced, or sold within the state. As a joint resolution, passage would require voter approval through a ballot measure.

Why is this important

Cannabis policy remains contentious across the U.S., with states taking divergent approaches to legalization, decriminalization, and product regulation. Missouri voters approved medical cannabis in 2018, making this amendment potentially significant for expanding or restricting access to cannabis-derived products like hemp, CBD, or other cannabinoid products. Constitutional amendments carry substantial weight as they override standard legislative processes and are difficult to reverse.

Potential points of contention

• Scope ambiguity: The bill's language regarding "products derived from cannabis plants" is broad and could include hemp-derived products (federally legal) or all cannabis products, creating regulatory uncertainty
• Existing medical program: Missouri has an established medical cannabis program; the amendment's relationship to this framework and whether it expands or restricts access remains unclear
• Public health concerns: Opponents may argue certain cannabis products lack adequate safety testing or age-restriction safeguards, while proponents may cite medical or economic benefits
• Federal-state conflict: Federal law classifies cannabis as Schedule I, potentially creating conflicts depending on how broadly the amendment defines covered products